Associated Papers
Somatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type.
Pinheiro M et al.
Nature Communications, 2024
39266536 (PubMed )
Supplement: 41467_2024_51713_MOESM5_ESM.xlsx › Data_2
Structural insights into the complex of oncogenic KRas4BG12V and Rgl2, a RalA/B activator.
Tariq M et al.
Life Science Alliance, 2024
Clinical and genetic characteristics in lymphoma patients with a second solid malignancy.
Zhou D et al.
Frontiers in Oncology, 2023
37546421 (PubMed )
Supplement: DataSheet_1.xlsx › Sheet1
Delineating the RAS Conformational Landscape.
Parker MI et al.
Cancer Research, 2022
35536216 (PubMed )
Supplement: can-22-0804_supplementary_datasets_s1-s4_suppsds1-sds4.xlsx › Supplementary_Dataset_S1
Structures of RGL1 RAS-Association Domain in Complex with KRAS and the Oncogenic G12V Mutant.
Eves BJ et al.
Journal of Molecular Biology, 2022
Structural bioinformatics enhances mechanistic interpretation of genomic variation, demonstrated through the analyses of 935 distinct RAS family mutations.
Tripathi S et al.
Bioinformatics (oxford, England), 2021
33226070 (PubMed )
Supplement: btaa972_supplementary_data.zip › RAS_Manuscript_RMarkdown.tar.gz › RAS_Manuscript1.Revised › RAS_Variants_Scores.xlsx › Sheet1
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J et al.
Bmc Cancer, 2021
33726687 (PubMed )
Supplement: 12885_2021_7942_MOESM3_ESM.xlsx › Table_S2
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.
Chae YK et al.
Oncotarget, 2016
27588476 (PubMed )
Supplement: oncotarget-07-65364-s001.pdf
Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
Stieglitz B et al.
The Embo Journal, 2008
Structural basis for the interaction of Ras with RalGDS.
Huang L et al.
Nature Structural Biology, 1998
Interactions of the amino acid residue at position 31 of the c-Ha-Ras protein with Raf-1 and RalGDS.
Shirouzu M et al.
The Journal of Biological Chemistry, 1998
Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1.
Hu CD et al.
The Journal of Biological Chemistry, 1997
Differential structural requirements for interaction of Ras protein with its distinct downstream effectors.
Akasaka K et al.
The Journal of Biological Chemistry, 1996
Point mutation of adenosine triphosphate-binding motif generated rigor kinesin that selectively blocks anterograde lysosome membrane transport.
Nakata T et al.
The Journal of Cell Biology, 1995
c-Ha-Ras mutants with point mutations in Gln-Val-Val region have reduced inhibitory activity toward cathepsin B.
Hiwasa T et al.
Cancer Letters, 1993
A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.
Rezaei Adariani S et al.
The Journal of Biological Chemistry, 0
33930461 (PubMed )
Supplement: mmc1.pdf
Select a paper to view details